The drug is given to
a subset of lung cancer patients at a daily dose of 150 mg, but whether this dosing strategy was the best way to prolong survival had not been empirically tested.
«First - line immunotherapy treatment can improve survival for
subset of lung cancer patients: Results of phase III global clinical trial show that 75 percent of stage IV lung cancer patients with both complex tumor mutations and PDL - 1 positive status respond to nivolumab.»
Not exact matches
If hypofractionated radiation with curative intent can reduce the treatment time for
lung cancer patients by half with no greater toxicity, and with equivalent — if not better — tumor control and survival outcomes, this research could result in a change in the paradigm
of how a large
subset of locally advanced NSCLC
patients are treated.»
«There has been a tremendous effort over the past several years to block EGFR as a treatment for
lung cancer, but this therapy only works in a small
subset of patients.
A
subset of these changes was much more prevalent in
lung -
cancer patients than
cancer - free smokers.